- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Alexion Pharmaceuticals Inc+ Add to Watchlist
ALXN:US125.4500 USD 3.2800 2.68%
As of 20:10:00 ET on 12/06/2013.
Company Profile for Alexion Pharmaceuticals Inc (ALXN)
Alexion Pharmaceuticals, Inc., a biopharmaceutical company, researches and develops proprietary immunoregulatory compounds for the treatment of autoimmune and cardiovascular diseases. The Company develops C5 complement inhibitors and Apogens which are two classes of potential therapeutic compounds designed to selectively target specific disease-causing segments of the immune system.
Alexion Pharmaceuticals Inc
Key Executives for Alexion Pharmaceuticals Inc (ALXN)
|Leonard BellCEO/Treasurer/Founder||Vikas SinhaExec VP/CFO|
|David L HallalExec VP/Chief Commercial Ofcr||Stephen P Squinto "Steve"Exec VP/Chief Global Ops Ofcr|
|Martin MackayExec VP/Global Head:R&D||Saqib IslamSenior VP/Chief Strategy Ofcr|
|Irving AdlerExec Dir:Corp Communications||Michael V GrecoSecretary/Associate Gen Cnsl|